For best results, follow a cycle of 3 months of use followed by a 1-month break, repeating the cycle again for another 3 months
Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists
This is a topic best explored in a dedicated GLP-1 weight loss consultation , where a provider can walk you through the differences based on your specific profile
GLP-Squared injections combine semaglutide with tirzepatide, creating a synergistic effect for patients who show partial response to monotherapy
The studies demonstrated substantial weight reduction, along with significant improvements in several obesity-associated comorbidities, including knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea (OSA), and type 2 diabetes
Recommended starting dose: 5 grams daily